DDW Highlights: 15 January 2024

01/15/24 • 15 min

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

This week has seen a number of significant discoveries by researchers in academic institutions, in some cases in partnership with industry, emphasising the important role universities play in early-stage drug discovery. Perhaps most importantly, a new antibiotic was found that targets a Gram-negative pathogen, mRNA was used as an effective therapy for a rare liver disease, and a common immune cell was found to attack cancer.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

Previous Episode

Revolutionary technology for drug discovery and development

This is the latest episode of the free DDW narrated podcast, titled “Revolutionary technology for drug discovery and development” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW.

They are called: mRNA technology may hold the future for a cytomegalovirus vaccine; Predictive diagnostics: closing the precision medicine gap; and FAIR Game: making data work harder in the race to market.

In the first article, Allison August, M.D., Vice President, Clinical Development, Infectious Diseases at Moderna examines the data on cytomegalovirus (CMV), why attempts at vaccines for CMV have so far proved elusive and the emerging options to address this unmet need.

In the second article, Jarret Glasscock, PhD, CEO of Cofactor Genomics explains how diagnostics are emerging as the key to ensuring the right patients get matched to the right therapy, at the right time.

In the third article, Dr Christof Gänzler, Product Marketing Biology at PerkinElmer Informatics, shares insight on making data work harder in the race to market.

You can also find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

Next Episode

Why is Europe a drug discovery epicentre?

This is the latest episode of the free DDW narrated podcast, titled: Why is Europe a drug discovery epicentre? It covers three articles written for Volume 23 – Issue 4, Fall 2022 of DDW.

They are called: European drug discovery and development success stories, Basel: A centre for ground-breaking oncology, and On the European CGT landscape, zebras and the future of medicine.

In the first article, Lu Rahman highlights some of the key players as, at the time of writing, we were starting to look beyond the pandemic, asking which areas of Europe’s drug discovery community we should be taking note of.

In the second article, Dr Stephan Emmerth and Paul Eschmann, Basel Area Business & Innovation, explain the benefits of being based in Basel – the talent pool, global players, academic institutions and investors, for example.

In the third article, Megan Thomas reflects on the cell and gene therapy landscape in Europe following Advanced Therapies Europe 2022.

You can also find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.